Compounds with dual action on cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) may be a treatment option for erectile dysfunction, as they not only promote penile erection but also prevent the upregulation of phosphodiesterase-5. In this study, we examined the possible relaxant effect and mechanism of 17-nor-subincanadine E (SEC, 0.2-200 mmol l 21 ), a plant-derived alkaloid, in rabbit corpus cavernosum (RbCC) strips that had been precontracted by exposure to phenylephrine (10 mmol l 21 ) or a high concentration of K 1 (60 mmol l 21 ) in vitro. In addition to SEC's effect on cAMP and cGMP levels, electrical field stimulation (EFS) in phenylephrine-precontracted RbCC and calcium chloride (1-100 mmol l 21 ) evoked responses in depolarized RbCC were analysed. SEC relaxed the phenylephrine-precontracted RbCCs in a concentration-dependent manner. Atropine, guanethidine and N-v-nitro-L-arginine methyl ester (L-NAME) did not have any effect on the relaxation of RBCCs. When 1H-1,2,4 oxadiazole[4,3-a] quinoxalin-1-one (ODQ) was added, it effectively blocked the relaxant response of SEC. Although SEC enhanced the maximal relaxation produced by sodium nitroprusside (SNP) and forskolin in phenylephrine-precontracted cavernosal smooth muscle, it caused a decrease in the maximal contractile response induced by calcium chloride in depolarized RbCCs. The relaxant effect of SEC was paralleled by an increase in the tissue levels of the cyclic nucleotides cAMP and cGMP. We conclude that SEC promotes the relaxation of RbCC, possibly favouring cAMP and cGMP accumulation and calcium blockade. This novel mechanism could be useful for patients who do not benefit from phosphodiesterase inhibitors and for those with endothelial and nitrergic dysfunction, such as patients with diabetes, hypertension and dyslipidaemias. Asian Journal of Andrology (2011) 13, 747-753; doi:10.1038/aja.2011.41; published online 18 July 2011
INTRODUCTION
The erect penis has always been a symbol of power, virility and fertility. Erectile dysfunction (ED) is the consistent inability to achieve and maintain an erection sufficient for satisfactory sexual activity. This condition is a complex neurovascular disorder that affects 52% of men aged 40-70 years and causes considerable distress, unhappiness and relationship problems for these men. 1, 2 Penile erection occurs as a function of trabecular smooth muscle relaxation and a subsequent increase in blood flow to lacunar spaces, which results in engorgement of the penis and restriction of venous drainage. Basically, the process is mediated by nitric oxide (NO) release from cavernosal nerve varicosities and endothelial cells, and this release activates intracellular guanylate cyclase to produce cGMP. 3 Recently, the selective phosphodiesterase 5 (PDE5) inhibitors sildenafil, tadalafil and vardenafil were shown to enhance the proerectile effect of NO by decreasing cGMP catabolism rates, thereby reinforcing the physiological signals that facilitate smooth muscle relaxation and erection; 4 however, their use is contraindicated with concomitant nitrate administration or alpha-adrenergic blockers. Furthermore, endothelial and nitrergic dysfunction, which are both progressive, are common in patients with ED associated with cardiovascular risk factors, such as those with diabetes and hypertension. Decreased synthesis and activity of NO associated with endothelial and nitrergic dysfunction may account for the observed tolerance and inefficacy (as high as 56%) of PDE5 inhibitors in these patients. 5 Increasing awareness of the adverse side effects with commonly prescribed medications on sexual function provides a rationale for developing new treatment strategies, and studies point out that compounds with dual action on cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) may be a treatment option for ED, as they not only promote penile erection but also prevent the upregulation of PDE5. 6, 7 Therefore, alternative forms of medical treatment remain clinically interesting, including the use of plant extracts, which many patients prefer as a treatment option. 8 Intense activity exists in the area of testing semipurified plant extracts for ED. Some plant-derived alkaloids, such as apomorphine, berberine, neferine and yohimbine, have been effective in alleviating impotence and ED. [9] [10] [11] [12] [13] Aspidosperma ulei (Markgr.) (Apocynaceae), which grows largely in the Amazon region of Brazil and elsewhere in South America, is a plant rich in indole alkaloids 14 and has an ethnomedicinal history as a traditional remedy for the treatment of ED. In the search for novel drugs effective against ED, our previous studies evaluated semi-purified extracts of Aspidosperma ulei, in vitro as well as in vivo, and the results obtained were encouraging. 15, 16 In a continuation study, we examined the effect of 17-nor-subincanadine E (SEC), a pure indole alkaloid isolated from the stem bark of Aspidosperma ulei, on penile erection-related behavioural responses in mice, and we found that SEC has a proerectile activity in vivo simulating yohimbine, a known indole alkaloid used to treat ED. 17 The present study aimed at assessing the possible relaxant effect of SEC on isolated rabbit corpus cavernosum (RbCC) strips and elucidating the underlying mechanism.
MATERIALS AND METHODS
Plant material and isolation of SEC Aspidosperma ulei (Markgr.) stem bark was collected from the Garapa area of Acarape, Ceará, Brazil, after its identification, and a specimen of the plant material has been deposited in Herbarium Prisco Bezerra (# 30823) of Federal University of Ceará, Fortaleza, Brazil, for future reference. The air-dried plant material (4.0 kg) was extracted with EtOH at room temperature. The corresponding extract (432.32 g, 10.81%) was designated AUE. AUE (20.7 g) was suspended in 200 ml of 2 mol l 21 HCl and was mixed by shaking for 30 min. The acid suspension was filtered under vacuum, and the resultant solution was partitioned with CH 2 Cl 2 (33200 ml), yielding 776.9 mg of a residue, designated AUEA, after work-up. The aqueous layer was alkalinized to pH 9 with NH 4 OH and extracted with CH 2 Cl 2 (33200 ml), yielding 781.8 mg of a residue designated AUEB. AUEA (350 mg) was preabsorbed on 500 mg of silica and was subjected to silica gel (2.5 g) chromatography by elution with a mixture of CH 2 Cl 2 -CH 3 OH (98 : 2-94 : 6), affording three subfractions. Among these, fraction 2 was identified as a new alkaloid named SEC (Figure 1) , by using spectroscopy analysis (mass spectrometry, infrared and nuclear magnetic resonance), including modern 2D NMR techniques and by comparison to data in the literature. 18 The characteristics of fraction 2 are as follows: 83.1 mg; melting point 229. 21 . Spectral details are provided as Supplemental information. The isolated compound was 95%-98% pure, with a molecular weight of 496.02.
Chemicals and reagents
Phenylephrine (PE), phentolamine hydrochloride, guanethidine atropine, N-v-nitro-L-arginine methyl ester (L-NAME), 1H- ). To obtain endothelial-denuded preparations, a thoracic aortic segment was rapidly removed and cut into rings (5 mm), and the vessel's lumen was gently rubbed. The procedure was considered successful when no relaxation was observed after a 1 mmol l 21 acetylcholine challenge. 20 These tissues were suspended on steel hooks, under 1 g of resting tension, in 5 ml organ baths containing Krebs-Henseleit solution gassed with 95% O 2 /5% CO 2 . The tension was recorded by force-displacement transducers (F-60; Narco Biosystems, Houston, TX, USA) coupled to a four-channel polygraph (Narco BioSystems). The tissues were allowed to equilibrate for 60 min, washing them every 15 min before starting any pharmacological observation. After an equilibration period of 1 h, tissues were precontracted, and the contraction tonic component was used as an internal standard control. After washing, an SEC concentration-response curve was performed in precontracted tissues, and the effect was expressed as the percentage of standard contraction. SEC effects were studied using two paired segments mounted on different baths and cumulatively increasing the SEC concentration in one bath while adding vehicle, isovolumetrically, to the other. The differences between the control baseline and test segment were used to express the relaxation induced by SEC. The relaxation (negative deflection) was measured and expressed as the percentage of maximal tonic contraction (positive deflection) induced by constrictor agents.
SEC relaxant effect on rabbit corpus cavernosa smooth muscle Male New Zealand white rabbits (6-month-old; 2.5-3.0 kg) were used. Study protocols were approved by the Institutional Ethics Committee of the Federal University of Ceará in accordance with the guidelines of National Institute of Health on the use and care of animals for experimentation. For experiments, animals were anesthetized with pentobarbital sodium (Hypnol, 35-40 mg kg 21 , i.v.) and were killed by exsanguination. The penis was removed at the level of corporal body attachment to the ischium and was immersed in cold Krebs solution (pH 7.4). The corporal tissues were carefully dissected free from the tunica albuginea, and strips were prepared and mounted under 1 g of resting tension in 5 ml organ baths filled with warmed (37 uC) and oxygenated (95% O 2 in Figure 1 Chemical structure of 17-nor-subincanadine E.
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OD Benvindo et al 748 5% CO 2 ) in Krebs solution. Following a 60-min equilibration period, tension was induced by adding PE (10 mmol l 21 ). At the contraction plateau, relaxation responses to cumulative concentrations (0.2-600 mmol l 21 ) of SEC were registered on a desk model polygraph (DMP-4B; Narco Bio-Systems) using a model FT-60 (Narco Bio-System) force-displacement transducer.
In separate experiments, when a stable contraction to PE (10 mmol l 21 ) was attained, SEC (0.2-200 mmol l
21
) was added to the organ bath in the presence of vehicle or one of the following pharmacological blockers: 10 mmol l 21 atropine, 100 mmol l 21 L-NAME or 100 mmol l 21 ODQ. SEC concentration-response curve was also obtained in 10 mmol l 21 phenylephrine-precontracted strips with 100 mmol l 21 glibenclamide or the combination of 1 mmol l 21 apamin plus 100 nmol l 21 iberiotoxin. Cavernosal strips were pre-incubated with the above pharmacological agents in the bath chamber for 30 min before the addition of SEC, and the curves were performed in the presence of these compounds. In another set of experiments, RbCCs were pre-treated for 30 min with 10 mmol l 21 guanethidine and 10 mmol l 21 phentolamine, and thereafter, an SEC concentration-response curve was performed in strips tonically precontracted with 60 mmol l 21 K
1
. When a stable contraction to PE (10 mmol l
21
) was reached, concentration-response curves for sodium nitrate (pH 2.0; 1-3000 nmol l Effect of SEC on electrical field stimulation (EFS)-induced cavernosal muscle relaxation EFS was accomplished by means of two platinum ring electrodes and a stimulus isolation unit in series with an S48 stimulator (Astro-Med Industrial Park, West Warwick, RI, USA). After an equilibration period, the strips were contracted with phenylephrine (10 mmol l 21 ). When the phenylephrine-induced contractile responses had stabilized, the tissue was subjected to the first EFSinduced relaxation at 20 V (0.5 ms pulse duration), using sequential frequencies of 0. ) was added to the tissue during tonic contraction. When drugs caused a maximal change in tension, the tissues were immediately frozen in liquid nitrogen. The frozen tissues were homogenized with a microhomogenizer in 1 ml 6% trichloroacetic acid containing 1 mmol l 21 EDTA. After centrifugation (3000g, 15 min, 4 uC), the supernatant was extracted with water-saturated diethyl ether, and aliquots of the aqueous phase were dried under nitrogen atmosphere and then reconstituted in the respective buffer kit (cAMP or cGMP) for analysis. Cyclic nucleotide solution levels were measured by the acetylation method with commercially available cAMP and cGMP immunoassay kits (Cayman Chemical Company, Ann Arbor, MI, USA). Protein content was determined using the Bradford method. 21 The cyclic nucleotide levels were expressed in pmol mg 21 protein.
Statistical analysis
The effect of SEC at each concentration was calculated as a percentage decrease from the maximal contractile responses of agonists. The concentration producing 50% of the maximal effect (EC 50 ) and the maximal effect were calculated for each agent. The differences between groups were verified using a one-way analysis of variance (ANOVA) followed by a Tukey-Kramer post hoc test with 5% significance. The data were analysed using SIGMA STAT software (Sigma Chemical Co., St Louis, MO, USA).
RESULTS
SEC evoked concentration-dependent relaxation in all tissues tested (i.e., the corpora cavernosa, endothelium-intact and endotheliumdenuded aortic rings, tracheal chains and the duodenum). Nevertheless, SEC was relatively selective for corpora cavernosa tissue, with an EC 50 approximately fourfold smaller than the calculated EC 50 for relaxation in aortic rings and approximately 10-fold smaller than the EC 50 for relaxation induced in tracheal rings and duodenum ( Table 1) . The EC 50 did not differ between endothelium-denuded and endothelium-intact aortic rings ( Table 1) .
The relaxant effect of SEC on RbCC strips was apparent after 2 mmol l 21 (11.3%) and was statistically significant at 6 mmol l
21
(28.3%); 20 mmol l 21 attained approximately equal to 60% level and, a more complete relaxation was apparent at higher concentrations (Figure 2a) . The SEC concentration-response curves obtained in phenylephrine-precontracted RbCC were unaffected by pretreatment with selective blockers of ATP-dependent potassium channels (K ATP ), glibenclamide or calcium-dependent potassium channels (K ca ), the combination of apamin and iberiotoxin (Figure 2b) . Similarly, the incubation of RbCC strips with 10 mmol l 21 atropine, a concentration that could completely block 1 mmol l 21 acetylcholineinduced relaxation, did not affect the SEC concentration-response curve (Figure 3a) .
In addition, the association of guanethidine, which is known to deplete catecholamine from nerve endings, and phentolamine, an alpha-adrenergic blocker, failed to alter the SEC concentrationresponse curve in K 1 (60 mmol l 21 ) precontracted RbCC strips (Figure 3b) . Similarly, a 30-min incubation period with L-NAME, a NO synthase inhibitor, did not have a significant influence on the concentration-dependent relaxation induced by SEC (Figure 4a and b) . However, the incubation of RbCC strips with ODQ, a selective, potent, non-competitive inhibitor of NO-stimulated sGC, shifted the SEC concentration-response curve to the right (Figure 4c) . SEC (20, Figure 5a ). The concentrationresponse curves for both sodium nitrate and forskolin were shifted upwards and to the left in tissues treated with SEC (Figure 5b) The relaxation evoked by transmural EFS at different frequencies was inhibited in a concentration-dependent fashion by a 20-min incubation period with SEC (2, 6 and 20 mmol l 21 ; Figure 5c ). The maximal relaxation observed at 16 Hz was 65% in control RbCC strips and was reduced to 55.1%, 31.2% and 10.8% in tissues pre-treated with 2, 6 and 20 mmol l 21 SEC, respectively (Figure 5c ). SEC also impaired the cumulative concentration-response curves for calcium chloride on isolated RbCC strips mounted in organ baths containing calcium-free depolarizing solution (Figure 6a) . The maximal contraction induced by this procedure was blocked by SEC (28.1%, 34.3% and 51.3% at 7, 15 and 30 mmol l 21 concentrations, respectively; Figure 5a) (Figure 6b and c) .
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DISCUSSION
RbCC has been a common experimental model for assessing the activity of compounds on erectile function, and cavernosum relaxation has been considered a positive result for the test substance. [22] [23] [24] [25] We used this in vitro system to characterize the relaxant effect of the plant alkaloid SEC and to study the underlying mechanism. SEC showed a concentration-dependent relaxant effect on phenylephrine-precontracted RbCC muscle, with an EC 50 of 13.6 mmol l 21 , which is four times lower than the EC 50 of 52.4 mmol l 21 , which was observed with aortic smooth muscle. Statistical differences were not found between maximal relaxation induced by SEC on endothelium-intact or endothelium-denuded aortic rings or in the calculated EC 50 , and this finding suggests that the endothelium is unlikely to have a primary role in vasorelaxation. This mechanism of action is different from another indole alkaloid, yohimbine, whose relaxant effect is endothelium-dependent. 23 Therefore, we assumed that endothelium-derived hyperpolarizing factor, NO and prostanoids (PGE 1 , PGE 2 and PGI 2 ), are probably not involved. The relaxation induced in aortic rings seems to be myogenic in regard to its pharmacological mechanisms.
SEC-induced relaxation was not dependent on K ATP or calciumactivated potassium channel activation, because it is insensitive to glibenclamide and iberiotoxin-apamin combinations. In addition, the relaxation induced by SEC occurred by a non-cholinergic, nonnoradrenergic mechanism, because it is insensitive to atropine and guanethidine-phentolamine combinations. In the present study, the effective blockage of SEC-induced relaxation by ODQ, but not L-NAME, may suggest that part of the SEC effect depends on a downstream effect in the NO-sGC-cGMP pathway.
This study has shown that SEC relaxes phenylephrine or high potassium-precontracted tissues with the same potency, raising the possibility for calcium antagonistic activity that does not occur in L-type voltagedependent calcium channels. The main possibility considered was that SEC can affect neuronal (N-type) calcium channels. In this context, it was suggested that within the corpus cavernosum, neuronal release or synthesis of NO partly depends on intracellular calcium bioavailability. 26 To Figure 6 (a) Concentration-response curves for calcium chloride (CaCl 2 , 1-300 mmol l 21 ) on rabbit corpora cavernosa (RbCC) strips. The curves were obtained by cumulatively increasing CaCl 2 in the organ bath where RbCC strips were kept in a 'calcium-free' medium enriched with K 1 (60 mmol l
21
). The curves were obtained in the absence or presence of 7-nor-subincanadine E (SEC) (SEC 3.5, SEC 7.5 and SEC 15 in graph represent 7, 15 and 30 mmol l 21 , respectively). Data are presented as mean6s.e.m. (n55) and were expressed as percentages of relaxation in relation to maximal contractile response (mN) in control tissues (i.e., not incubated with SEC). Data are expressed as mean6s.e.m. (n54). *P,0.05 vs. control. (b, c) Cyclic nucleotides (cGMP and cAMP) levels in homogenates of RbCC strips were incubated with SEC (15 and 30 mmol l 21 ) or positive controls (FK for cAMP and SNP for cGMP). The strips were mounted in organ baths and incubated with specific drugs, and after the relaxant effect plateau, they were rapidly frozen in liquid nitrogen and stored at 280 uC until assays were performed. The measurement was performed by using commercially available kits for immunoassays (Cayman, Ann Arbour, MI, USA). Data are expressed as mean6s.e.m. (n54 in triplicates). ***P,0.001, vs. control (basal level), analysis of variance (ANOVA) followed by Tukey-Kramer test. cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; SNP, sodium nitroprusside.
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OD Benvindo et al 752 elucidate the mechanism of SEC-mediated relaxation, its effects on EFS and tissue levels of cAMP and cGMP in phenylephrine-precontracted RbCC were analysed. It was found that nerve-mediated relaxation is inhibited by SEC at 6 and 10 mmol l 21 in a concentration-related manner. The inhibitory effect may be related to calcium antagonism by SEC in nitrergic nerve endings leading to decreased activation of neuronal NOS (a calcium-dependent enzyme). In this regard, an earlier study pointed out that blockade of N-type, but not L-type, voltage-dependent calcium channels inhibits the transmural electrical field-evoked relaxation. 27 Furthermore, a related fraction of alkaloids from this plant was shown to inhibit calcium uptake in rat cortical synaptosomes (unpublished observations). On the other hand, a classical NOS inhibitor would not decrease corpora cavernosa smooth muscle tonus in a concentrationrelated fashion as with SEC. Indeed, NOS inhibition and sGC inhibition would increase smooth muscle tonus. In our control experiments, NOS inhibition or sGC inhibition only evoked sustained increase in tonus (data not shown). In this regard, it has been shown that the increase in cGMP in nerve varicosities has a negative effect on electrical field-induced relaxation by an unknown molecular mechanism. 28 The possibility that specific inhibition of neuronal nitric oxide synthase by phosphorylation has a role on SEC effect was not ruled out and needs to be addressed in a future study.
SEC at 15 mmol l 21 effectively relaxes (45%) phenylephrineprecontracted corpus cavernosum tissues without producing an observable change in tissue levels of cyclic nucleotides, but at 30 mmol l 21 , its relaxant effect (65%) was associated with significant increases of cAMP and cGMP, which may be a consequence of enhanced biosynthesis. Interestingly, increases in both cGMP and cAMP are related to penile erection and there seems to have a cross-talk signalling between these nucleotides in the regulation of penile smooth muscle tone. 29, 30 For instance, increased levels of cGMP decreased the rate of cAMP hydrolysis. In this context, a previous study has shown that sildenafil, a clinically useful drug for ED, increases both cAMP and cGMP in isolated human corpus cavernosum. 31 However, further experimentation is needed to better understand the communication between different phosphodiesterases and to determine SEC activity against a full range of phosphodiestrases isoenzymes, its proerectile effect in vivo, and whether it would enhance intracavernous pressure.
In conclusion, our data demonstrated for the first time that the plant alkaloid SEC from Aspidosperma ulei stem bark exerts a potent relaxant effect on rabbit corpus cavernosum smooth muscle in vitro by a mechanism that is partly independent of the classical nitric oxide pathway and may bypass nitrergic and endothelial dysfunctions associated with several cardiovascular risk factors that contribute to ED, such as diabetes, hypertension and dyslipidaemia.
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